| |
| |
|
| Insider
Information: |
Young David |
| Relationship: |
|
| City: |
Columbia |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
79,387 |
|
|
Indirect Shares
|
70,940 |
|
|
| Direct
Value |
$17,862 |
|
|
|
Indirect Value
|
$13,571 |
|
|
| Total
Shares |
150,327 |
|
|
| Total
Value |
$31,433 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-6.0
|
0.0
|
| Percentage
Gain/Loss : |
 -32.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Chief Scientific Officer |
2014-08-14 |
0 |
2013-03-07 |
10,625 |
Premium* |
|
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2024-02-07 |
79,387 |
2024-02-07 |
60,315 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCSA |
Processa Pharmaceuticals,... |
Chief Executive OfficerOfficer |
• • – |
2020-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
335,190 |
|
% |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Executive OfficerOfficer |
• • – |
2020-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,293,045 |
|
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-02-24 |
4/A |
A |
$0.00 |
$0 |
D/D |
71,325 |
85,821 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
71,332 |
85,235 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-03-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,625 |
10,625 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-03-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,625 |
75,666 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-02-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,667) |
122,478 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
139,145 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-08-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(117,741) |
0 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Executive Officer |
• • • |
2021-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,601 |
381,964 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2022-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,601 |
389,565 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2022-08-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,250 |
377,784 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Pres. Research & Development |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,675 |
81,062 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Pres. Research & Development |
• • • |
2023-10-10 |
4 |
A |
$0.24 |
$34,080 |
D/D |
142,000 |
612,424 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Pres. Research & Development |
• • • |
2023-10-12 |
4 |
A |
$0.29 |
$45,030 |
D/D |
155,277 |
767,701 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2010-11-02 |
4 |
OE |
$0.43 |
$31,444 |
D/D |
28,125 |
36,422 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2023-04-12 |
4 |
B |
$0.45 |
$9,000 |
D/D |
20,000 |
390,424 |
0.01 |
% |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2023-04-13 |
4 |
B |
$0.48 |
$9,600 |
D/D |
20,000 |
410,424 |
0.01 |
% |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2023-04-11 |
4 |
B |
$0.52 |
$10,400 |
D/D |
20,000 |
370,424 |
0.01 |
% |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2023-04-14 |
4 |
B |
$0.55 |
$10,998 |
D/D |
20,000 |
430,424 |
0.01 |
% |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2023-02-09 |
4 |
A |
$0.80 |
$15,000 |
D/D |
18,750 |
350,424 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2023-06-12 |
4 |
B |
$0.80 |
$32,000 |
D/D |
40,000 |
470,424 |
0.01 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2012-08-10 |
4 |
OE |
$1.47 |
$46,319 |
D/D |
10,625 |
13,903 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2011-08-05 |
4 |
OE |
$1.64 |
$16,400 |
D/D |
10,000 |
18,402 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2011-08-12 |
4 |
OE |
$1.64 |
$15,101 |
D/D |
9,208 |
17,610 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
